This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
By Nischay Mittal, Partner & Global Head – Automation/AI, Zinnov; Prankur Sharma, Engagement Manager – Automation/AI, Zinnov; Sukrit Kumar, Project Lead, Zinnov. It is one, amongst a handful of USD 500 Mn+ Automation powerhouses, with over 25,000 customers today. Kofax’s Journey so Far.
In California, the contract that just ended on July 1 st , 2022, was part of an extension of a previous agreement between the union and management in 2017. Automation is the answer to many of the bottleneck and inefficiency problems the ports are experiencing. A Different Kind of Disruption. All good advice!
Along with these challenges, the ongoing drive to reduce costs, improve efficiency and productivity, drive better decision-making and reduce risk will continue to drive pharma investment in cloud, AI/ML, analytics and automation in 2023 despite higher interest rates. Since then, more than 20 cell and gene therapy products have been approved.
We organize all of the trending information in your field so you don't have to. Join 19,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
2017 
59 
Let's personalize your content